Summit Therapeutics Inc.Summit Therapeutics Inc.Summit Therapeutics Inc.

Summit Therapeutics Inc.

No trades
See on Supercharts

Price target

7.500.00 0.00%
The 2 analysts offering 1 year price forecasts for SMMT have a max estimate of — and a min estimate of —.

Analyst rating

Based on 2 analysts giving stock ratings to SMMT in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

SMMT EPS for the last quarter is −0.06 USD despite the estimation of −0.06 USD. In the next quarter EPS is expected to reach −0.06 USD. Track more of Summit Therapeutics Inc. financials and stay on top of what is up with the company.
In the next quarter Summit Therapeutics Inc. revenue is expected to reach 0 USD. Check out Summit Therapeutics Inc. revenue and earnings and make informed decisions.
According to analysts, SMMT price target is 7.50 USD with a max estimate of 8.00 USD and a min estimate of 7.00 USD. Check if this forecast comes true in a year, meanwhile watch Summit Therapeutics Inc. stock price chart and keep track of the current situation with SMMT news and stock market news.